Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial.
Gianmarco Iannopollo, Marta Cocco, Alessandro Leone...
https://pubmed.ncbi.nlm.nih.gov/39505122/Actively Recruiting
Led by University Hospital of Ferrara · Updated on 2026-08-21
1612
Participants Needed
11
Research Sites
208 weeks
Total Duration
The trial investigates whether transcatheter aortic valve implantation TAVI can be safely and effectively performed in hospitals without on-site cardiac surgery for patients with severe symptomatic aortic stenosis. This multicenter, randomized study compares outcomes between centers with and without on-site cardiac surgery to determine if patient safety is maintained when appropriate selection, experienced operators, advanced imaging, and transfer plans are in place. The goal is to improve access to timely treatment while ensuring clinical safety at 1 year. Participants will be randomly assigned to receive TAVI either in a center without on-site cardiac surgery or in a center with on-site cardiac surgery. Both groups undergo the procedure performed by experienced operators following current guidelines and standards. Centers without on-site surgery must have advanced imaging, procedural expertise, and established transfer pathways. Patients will be evaluated beforehand with clinical, echocardiographic, laboratory, coronary, and computed tomography assessments to confirm eligibility and procedural feasibility. During the study, participants will be monitored for clinical outcomes including death from any cause, stroke, and hospitalizations related to the procedure or implanted valve at 1 year. Safety events such as valve-related death and major complications will also be recorded. Clinical events will be reviewed by an independent committee blinded to treatment assignment, and patient safety will be overseen by a data monitoring board. After hospital discharge, participants will have structured follow-up visits to assess health status, adverse events, and hospitalizations, with total participation lasting up to 1 year.
CONDITIONS
TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery
G
Gianluca Campo, MD
A
Alice Santoni
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital of Ferrara
Lead Sponsor
Consorzio Futuro in Ricerca
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 4 weeks
Participants are evaluated for eligibility through clinical, imaging, and laboratory tests to confirm suitability for TAVI and study inclusion.
1 to 2 visits
Duration - Procedure day and hospital stay
Participants undergo transcatheter aortic valve implantation at a center assigned by randomization, either with or without on-site cardiac surgery, performed by experienced operators.
1 procedure visit and hospital monitoring
Duration - 12 months
Participants are monitored for clinical outcomes including survival, stroke, and hospitalizations related to the procedure or valve over one year after treatment.
Regular follow-up visits over 1 year
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Gianmarco Iannopollo, Marta Cocco, Alessandro Leone...
https://pubmed.ncbi.nlm.nih.gov/39505122/University Hospital of Ferrara
Lead Sponsor
Consorzio Futuro in Ricerca
Collaborating Sponsor